Creo Salient (Cramlington, UK) is a CDMO for HPAPI (highly potent API) and cytotoxic compounds. OEB 4/5 containment. Antibody-drug conjugate (ADC) payloads and linkers. Safe handling of compounds down to 0.01 µg/m³ OEL.
12:45:02 AM · Jul 9, 2026
Sign in to reply and join the conversation.